nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.021	0.0212	CcSEcCtD
Lercanidipine—Myositis—Telbivudine—hepatitis B	0.0205	0.0206	CcSEcCtD
Lercanidipine—Serum creatinine increased—Entecavir—hepatitis B	0.0199	0.02	CcSEcCtD
Lercanidipine—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0194	0.0196	CcSEcCtD
Lercanidipine—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.0175	0.0176	CcSEcCtD
Lercanidipine—Autoimmune disorder—Lamivudine—hepatitis B	0.0169	0.0171	CcSEcCtD
Lercanidipine—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0149	0.015	CcSEcCtD
Lercanidipine—Laryngeal pain—Telbivudine—hepatitis B	0.0147	0.0149	CcSEcCtD
Lercanidipine—Hoarseness—Lamivudine—hepatitis B	0.0129	0.013	CcSEcCtD
Lercanidipine—Rhinorrhoea—Telbivudine—hepatitis B	0.0124	0.0125	CcSEcCtD
Lercanidipine—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.0119	0.012	CcSEcCtD
Lercanidipine—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0117	0.0118	CcSEcCtD
Lercanidipine—Hepatic failure—Entecavir—hepatitis B	0.00986	0.00996	CcSEcCtD
Lercanidipine—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00984	0.00994	CcSEcCtD
Lercanidipine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00962	0.00972	CcSEcCtD
Lercanidipine—Blood triglycerides increased—Lamivudine—hepatitis B	0.00863	0.00871	CcSEcCtD
Lercanidipine—Bone marrow depression—Lamivudine—hepatitis B	0.00837	0.00845	CcSEcCtD
Lercanidipine—Blood creatinine increased—Entecavir—hepatitis B	0.0083	0.00838	CcSEcCtD
Lercanidipine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0081	0.00818	CcSEcCtD
Lercanidipine—Abdominal pain upper—Entecavir—hepatitis B	0.0081	0.00817	CcSEcCtD
Lercanidipine—Throat sore—Lamivudine—hepatitis B	0.00784	0.00792	CcSEcCtD
Lercanidipine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00777	0.00785	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00763	0.0077	CcSEcCtD
Lercanidipine—Pancreatitis—Entecavir—hepatitis B	0.00751	0.00758	CcSEcCtD
Lercanidipine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00733	0.0074	CcSEcCtD
Lercanidipine—Migraine—Telbivudine—hepatitis B	0.00717	0.00724	CcSEcCtD
Lercanidipine—Neutropenia—Entecavir—hepatitis B	0.00716	0.00723	CcSEcCtD
Lercanidipine—Rhinorrhoea—Lamivudine—hepatitis B	0.00698	0.00704	CcSEcCtD
Lercanidipine—Dysphonia—Lamivudine—hepatitis B	0.00687	0.00694	CcSEcCtD
Lercanidipine—Renal failure—Entecavir—hepatitis B	0.00672	0.00678	CcSEcCtD
Lercanidipine—Abdominal pain upper—Telbivudine—hepatitis B	0.00665	0.00671	CcSEcCtD
Lercanidipine—Cramp muscle—Telbivudine—hepatitis B	0.00656	0.00662	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00656	0.00662	CcSEcCtD
Lercanidipine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00655	0.00661	CcSEcCtD
Lercanidipine—Nasopharyngitis—Telbivudine—hepatitis B	0.00651	0.00657	CcSEcCtD
Lercanidipine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0065	0.00656	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Entecavir—hepatitis B	0.00646	0.00652	CcSEcCtD
Lercanidipine—Muscular weakness—Telbivudine—hepatitis B	0.00642	0.00648	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00642	0.00648	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0063	0.00636	CcSEcCtD
Lercanidipine—Oropharyngeal pain—Lamivudine—hepatitis B	0.00622	0.00628	CcSEcCtD
Lercanidipine—Hepatitis—Entecavir—hepatitis B	0.00613	0.00619	CcSEcCtD
Lercanidipine—Oedema peripheral—Entecavir—hepatitis B	0.00604	0.0061	CcSEcCtD
Lercanidipine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00598	0.00604	CcSEcCtD
Lercanidipine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00598	0.00603	CcSEcCtD
Lercanidipine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00591	0.00596	CcSEcCtD
Lercanidipine—Neutropenia—Telbivudine—hepatitis B	0.00589	0.00594	CcSEcCtD
Lercanidipine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00588	0.00594	CcSEcCtD
Lercanidipine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00587	0.00592	CcSEcCtD
Lercanidipine—Vasculitis—Lamivudine—hepatitis B	0.00579	0.00585	CcSEcCtD
Lercanidipine—Immune system disorder—Entecavir—hepatitis B	0.00554	0.00559	CcSEcCtD
Lercanidipine—Renal failure—Telbivudine—hepatitis B	0.00552	0.00557	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Telbivudine—hepatitis B	0.0055	0.00555	CcSEcCtD
Lercanidipine—Alopecia—Entecavir—hepatitis B	0.00542	0.00547	CcSEcCtD
Lercanidipine—Mental disorder—Entecavir—hepatitis B	0.00537	0.00542	CcSEcCtD
Lercanidipine—Malnutrition—Entecavir—hepatitis B	0.00534	0.00539	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00531	0.00536	CcSEcCtD
Lercanidipine—Nilvadipine—CYP2A6—hepatitis B	0.00529	0.565	CrCbGaD
Lercanidipine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00521	0.00526	CcSEcCtD
Lercanidipine—Urine output increased—Lamivudine—hepatitis B	0.00511	0.00516	CcSEcCtD
Lercanidipine—Gynaecomastia—Lamivudine—hepatitis B	0.00506	0.00511	CcSEcCtD
Lercanidipine—Hepatitis—Telbivudine—hepatitis B	0.00504	0.00509	CcSEcCtD
Lercanidipine—Connective tissue disorder—Telbivudine—hepatitis B	0.00495	0.005	CcSEcCtD
Lercanidipine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00481	0.00486	CcSEcCtD
Lercanidipine—Lymphadenopathy—Lamivudine—hepatitis B	0.00481	0.00486	CcSEcCtD
Lercanidipine—Sleep disorder—Lamivudine—hepatitis B	0.00474	0.00479	CcSEcCtD
Lercanidipine—Polyuria—Lamivudine—hepatitis B	0.00467	0.00472	CcSEcCtD
Lercanidipine—Cough—Adefovir Dipivoxil—hepatitis B	0.00455	0.00459	CcSEcCtD
Lercanidipine—Mediastinal disorder—Telbivudine—hepatitis B	0.00454	0.00458	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00451	0.00456	CcSEcCtD
Lercanidipine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00443	0.00448	CcSEcCtD
Lercanidipine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00443	0.00448	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0044	0.00445	CcSEcCtD
Lercanidipine—Malnutrition—Telbivudine—hepatitis B	0.00439	0.00443	CcSEcCtD
Lercanidipine—Dysgeusia—Telbivudine—hepatitis B	0.00429	0.00434	CcSEcCtD
Lercanidipine—Nervous system disorder—Entecavir—hepatitis B	0.00427	0.00431	CcSEcCtD
Lercanidipine—Skin disorder—Entecavir—hepatitis B	0.00423	0.00427	CcSEcCtD
Lercanidipine—Muscle spasms—Telbivudine—hepatitis B	0.00422	0.00426	CcSEcCtD
Lercanidipine—Hypoglycaemia—Lamivudine—hepatitis B	0.00421	0.00424	CcSEcCtD
Lercanidipine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00417	0.00421	CcSEcCtD
Lercanidipine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00416	0.0042	CcSEcCtD
Lercanidipine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00413	0.00417	CcSEcCtD
Lercanidipine—Nifedipine—CYP2A6—hepatitis B	0.00408	0.435	CrCbGaD
Lercanidipine—Ill-defined disorder—Telbivudine—hepatitis B	0.00407	0.00411	CcSEcCtD
Lercanidipine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00405	0.00409	CcSEcCtD
Lercanidipine—Migraine—Lamivudine—hepatitis B	0.00404	0.00408	CcSEcCtD
Lercanidipine—Malaise—Telbivudine—hepatitis B	0.00395	0.00399	CcSEcCtD
Lercanidipine—Insomnia—Entecavir—hepatitis B	0.00394	0.00398	CcSEcCtD
Lercanidipine—Somnolence—Entecavir—hepatitis B	0.00387	0.00391	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00387	0.00391	CcSEcCtD
Lercanidipine—Dyspepsia—Entecavir—hepatitis B	0.00384	0.00387	CcSEcCtD
Lercanidipine—Cough—Telbivudine—hepatitis B	0.00383	0.00386	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00376	0.0038	CcSEcCtD
Lercanidipine—Fatigue—Entecavir—hepatitis B	0.00376	0.00379	CcSEcCtD
Lercanidipine—Abdominal pain upper—Lamivudine—hepatitis B	0.00375	0.00378	CcSEcCtD
Lercanidipine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00374	0.00378	CcSEcCtD
Lercanidipine—Chest pain—Telbivudine—hepatitis B	0.00373	0.00377	CcSEcCtD
Lercanidipine—Myalgia—Telbivudine—hepatitis B	0.00373	0.00377	CcSEcCtD
Lercanidipine—Arthralgia—Telbivudine—hepatitis B	0.00373	0.00377	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00371	0.00374	CcSEcCtD
Lercanidipine—Cramp muscle—Lamivudine—hepatitis B	0.0037	0.00373	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.0037	0.00373	CcSEcCtD
Lercanidipine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0037	0.00373	CcSEcCtD
Lercanidipine—Discomfort—Telbivudine—hepatitis B	0.00369	0.00372	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00367	0.0037	CcSEcCtD
Lercanidipine—Nasopharyngitis—Lamivudine—hepatitis B	0.00367	0.0037	CcSEcCtD
Lercanidipine—Muscular weakness—Lamivudine—hepatitis B	0.00362	0.00365	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00362	0.00365	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Entecavir—hepatitis B	0.00356	0.0036	CcSEcCtD
Lercanidipine—Nervous system disorder—Telbivudine—hepatitis B	0.00351	0.00354	CcSEcCtD
Lercanidipine—Thrombocytopenia—Telbivudine—hepatitis B	0.0035	0.00354	CcSEcCtD
Lercanidipine—Pancreatitis—Lamivudine—hepatitis B	0.00348	0.00351	CcSEcCtD
Lercanidipine—Skin disorder—Telbivudine—hepatitis B	0.00348	0.00351	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00348	0.00351	CcSEcCtD
Lercanidipine—Sweating increased—Lamivudine—hepatitis B	0.00346	0.00349	CcSEcCtD
Lercanidipine—Abdominal pain—Entecavir—hepatitis B	0.00344	0.00348	CcSEcCtD
Lercanidipine—Body temperature increased—Entecavir—hepatitis B	0.00344	0.00348	CcSEcCtD
Lercanidipine—Pancytopenia—Lamivudine—hepatitis B	0.00337	0.0034	CcSEcCtD
Lercanidipine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00336	0.00339	CcSEcCtD
Lercanidipine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00336	0.00339	CcSEcCtD
Lercanidipine—Neutropenia—Lamivudine—hepatitis B	0.00332	0.00335	CcSEcCtD
Lercanidipine—Pollakiuria—Lamivudine—hepatitis B	0.00328	0.00331	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00326	0.00329	CcSEcCtD
Lercanidipine—Insomnia—Telbivudine—hepatitis B	0.00324	0.00327	CcSEcCtD
Lercanidipine—Paraesthesia—Telbivudine—hepatitis B	0.00321	0.00324	CcSEcCtD
Lercanidipine—Dyspepsia—Telbivudine—hepatitis B	0.00315	0.00318	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00314	0.00317	CcSEcCtD
Lercanidipine—Asthenia—Entecavir—hepatitis B	0.00313	0.00316	CcSEcCtD
Lercanidipine—Renal failure—Lamivudine—hepatitis B	0.00311	0.00314	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Lamivudine—hepatitis B	0.0031	0.00313	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00309	0.00312	CcSEcCtD
Lercanidipine—Fatigue—Telbivudine—hepatitis B	0.00309	0.00311	CcSEcCtD
Lercanidipine—Stomatitis—Lamivudine—hepatitis B	0.00308	0.00311	CcSEcCtD
Lercanidipine—Jaundice—Lamivudine—hepatitis B	0.00308	0.00311	CcSEcCtD
Lercanidipine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00305	0.00308	CcSEcCtD
Lercanidipine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00301	0.00304	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00299	0.00302	CcSEcCtD
Lercanidipine—Diarrhoea—Entecavir—hepatitis B	0.00298	0.00301	CcSEcCtD
Lercanidipine—Agranulocytosis—Lamivudine—hepatitis B	0.00295	0.00298	CcSEcCtD
Lercanidipine—Feeling abnormal—Telbivudine—hepatitis B	0.00295	0.00298	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00293	0.00295	CcSEcCtD
Lercanidipine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00291	0.00294	CcSEcCtD
Lercanidipine—Dizziness—Entecavir—hepatitis B	0.00288	0.00291	CcSEcCtD
Lercanidipine—Rhinitis—Lamivudine—hepatitis B	0.00285	0.00287	CcSEcCtD
Lercanidipine—Hepatitis—Lamivudine—hepatitis B	0.00284	0.00287	CcSEcCtD
Lercanidipine—Abdominal pain—Telbivudine—hepatitis B	0.00283	0.00286	CcSEcCtD
Lercanidipine—Body temperature increased—Telbivudine—hepatitis B	0.00283	0.00286	CcSEcCtD
Lercanidipine—Connective tissue disorder—Lamivudine—hepatitis B	0.00279	0.00282	CcSEcCtD
Lercanidipine—Vomiting—Entecavir—hepatitis B	0.00277	0.0028	CcSEcCtD
Lercanidipine—Rash—Entecavir—hepatitis B	0.00275	0.00277	CcSEcCtD
Lercanidipine—Dermatitis—Entecavir—hepatitis B	0.00274	0.00277	CcSEcCtD
Lercanidipine—Headache—Entecavir—hepatitis B	0.00273	0.00276	CcSEcCtD
Lercanidipine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0027	0.00273	CcSEcCtD
Lercanidipine—Erythema multiforme—Lamivudine—hepatitis B	0.00268	0.00271	CcSEcCtD
Lercanidipine—Rash—Adefovir Dipivoxil—hepatitis B	0.00268	0.00271	CcSEcCtD
Lercanidipine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00268	0.0027	CcSEcCtD
Lercanidipine—Headache—Adefovir Dipivoxil—hepatitis B	0.00266	0.00269	CcSEcCtD
Lercanidipine—Nausea—Entecavir—hepatitis B	0.00259	0.00261	CcSEcCtD
Lercanidipine—Asthenia—Telbivudine—hepatitis B	0.00257	0.00259	CcSEcCtD
Lercanidipine—Immune system disorder—Lamivudine—hepatitis B	0.00256	0.00259	CcSEcCtD
Lercanidipine—Mediastinal disorder—Lamivudine—hepatitis B	0.00256	0.00258	CcSEcCtD
Lercanidipine—Pruritus—Telbivudine—hepatitis B	0.00253	0.00256	CcSEcCtD
Lercanidipine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00252	0.00255	CcSEcCtD
Lercanidipine—Alopecia—Lamivudine—hepatitis B	0.00251	0.00253	CcSEcCtD
Lercanidipine—Erythema—Lamivudine—hepatitis B	0.00247	0.00249	CcSEcCtD
Lercanidipine—Malnutrition—Lamivudine—hepatitis B	0.00247	0.00249	CcSEcCtD
Lercanidipine—Diarrhoea—Telbivudine—hepatitis B	0.00245	0.00247	CcSEcCtD
Lercanidipine—Tension—Lamivudine—hepatitis B	0.00243	0.00245	CcSEcCtD
Lercanidipine—Dysgeusia—Lamivudine—hepatitis B	0.00242	0.00244	CcSEcCtD
Lercanidipine—Nervousness—Lamivudine—hepatitis B	0.0024	0.00242	CcSEcCtD
Lercanidipine—Muscle spasms—Lamivudine—hepatitis B	0.00238	0.0024	CcSEcCtD
Lercanidipine—Dizziness—Telbivudine—hepatitis B	0.00237	0.00239	CcSEcCtD
Lercanidipine—Ill-defined disorder—Lamivudine—hepatitis B	0.00229	0.00231	CcSEcCtD
Lercanidipine—Anaemia—Lamivudine—hepatitis B	0.00228	0.00231	CcSEcCtD
Lercanidipine—Vomiting—Telbivudine—hepatitis B	0.00228	0.0023	CcSEcCtD
Lercanidipine—Angioedema—Lamivudine—hepatitis B	0.00226	0.00228	CcSEcCtD
Lercanidipine—Rash—Telbivudine—hepatitis B	0.00226	0.00228	CcSEcCtD
Lercanidipine—Dermatitis—Telbivudine—hepatitis B	0.00225	0.00228	CcSEcCtD
Lercanidipine—Headache—Telbivudine—hepatitis B	0.00224	0.00226	CcSEcCtD
Lercanidipine—Malaise—Lamivudine—hepatitis B	0.00223	0.00225	CcSEcCtD
Lercanidipine—Vertigo—Lamivudine—hepatitis B	0.00222	0.00224	CcSEcCtD
Lercanidipine—Syncope—Lamivudine—hepatitis B	0.00222	0.00224	CcSEcCtD
Lercanidipine—Loss of consciousness—Lamivudine—hepatitis B	0.00217	0.00219	CcSEcCtD
Lercanidipine—Cough—Lamivudine—hepatitis B	0.00216	0.00218	CcSEcCtD
Lercanidipine—Nausea—Telbivudine—hepatitis B	0.00213	0.00215	CcSEcCtD
Lercanidipine—Arthralgia—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Lercanidipine—Chest pain—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Lercanidipine—Myalgia—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Lercanidipine—Anxiety—Lamivudine—hepatitis B	0.0021	0.00212	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00209	0.00211	CcSEcCtD
Lercanidipine—Discomfort—Lamivudine—hepatitis B	0.00208	0.0021	CcSEcCtD
Lercanidipine—Dry mouth—Lamivudine—hepatitis B	0.00206	0.00208	CcSEcCtD
Lercanidipine—Confusional state—Lamivudine—hepatitis B	0.00203	0.00205	CcSEcCtD
Lercanidipine—Shock—Lamivudine—hepatitis B	0.00198	0.002	CcSEcCtD
Lercanidipine—Nervous system disorder—Lamivudine—hepatitis B	0.00198	0.002	CcSEcCtD
Lercanidipine—Thrombocytopenia—Lamivudine—hepatitis B	0.00197	0.00199	CcSEcCtD
Lercanidipine—Skin disorder—Lamivudine—hepatitis B	0.00196	0.00198	CcSEcCtD
Lercanidipine—Hyperhidrosis—Lamivudine—hepatitis B	0.00195	0.00197	CcSEcCtD
Lercanidipine—Anorexia—Lamivudine—hepatitis B	0.00192	0.00194	CcSEcCtD
Lercanidipine—Hypotension—Lamivudine—hepatitis B	0.00188	0.0019	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00184	0.00186	CcSEcCtD
Lercanidipine—Insomnia—Lamivudine—hepatitis B	0.00182	0.00184	CcSEcCtD
Lercanidipine—Paraesthesia—Lamivudine—hepatitis B	0.00181	0.00183	CcSEcCtD
Lercanidipine—Dyspnoea—Lamivudine—hepatitis B	0.0018	0.00182	CcSEcCtD
Lercanidipine—Somnolence—Lamivudine—hepatitis B	0.00179	0.00181	CcSEcCtD
Lercanidipine—Dyspepsia—Lamivudine—hepatitis B	0.00178	0.00179	CcSEcCtD
Lercanidipine—Decreased appetite—Lamivudine—hepatitis B	0.00175	0.00177	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00174	0.00176	CcSEcCtD
Lercanidipine—Fatigue—Lamivudine—hepatitis B	0.00174	0.00176	CcSEcCtD
Lercanidipine—Constipation—Lamivudine—hepatitis B	0.00172	0.00174	CcSEcCtD
Lercanidipine—Feeling abnormal—Lamivudine—hepatitis B	0.00166	0.00168	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00165	0.00167	CcSEcCtD
Lercanidipine—Urticaria—Lamivudine—hepatitis B	0.0016	0.00162	CcSEcCtD
Lercanidipine—Abdominal pain—Lamivudine—hepatitis B	0.00159	0.00161	CcSEcCtD
Lercanidipine—Body temperature increased—Lamivudine—hepatitis B	0.00159	0.00161	CcSEcCtD
Lercanidipine—Hypersensitivity—Lamivudine—hepatitis B	0.00149	0.0015	CcSEcCtD
Lercanidipine—Asthenia—Lamivudine—hepatitis B	0.00145	0.00146	CcSEcCtD
Lercanidipine—Pruritus—Lamivudine—hepatitis B	0.00143	0.00144	CcSEcCtD
Lercanidipine—Diarrhoea—Lamivudine—hepatitis B	0.00138	0.00139	CcSEcCtD
Lercanidipine—Dizziness—Lamivudine—hepatitis B	0.00133	0.00135	CcSEcCtD
Lercanidipine—Vomiting—Lamivudine—hepatitis B	0.00128	0.00129	CcSEcCtD
Lercanidipine—Rash—Lamivudine—hepatitis B	0.00127	0.00128	CcSEcCtD
Lercanidipine—Dermatitis—Lamivudine—hepatitis B	0.00127	0.00128	CcSEcCtD
Lercanidipine—Headache—Lamivudine—hepatitis B	0.00126	0.00128	CcSEcCtD
Lercanidipine—Nausea—Lamivudine—hepatitis B	0.0012	0.00121	CcSEcCtD
